Individual Neoantigen Therapy
$0.00000252
$0.00000252
$2.52K
$2.40K
$133.40K
$2.52K
Price Changes
5 Minutes
-1.57%
1 Hour
-91.75%
6 Hours
-91.75%
24 Hours
-91.75%
Token Details
A6Mr64...YTpumpGet Full Analysis for INT
Access AI-powered rug pull detection, smart money tracking, holder distribution, TradingView charts, and deep on-chain analytics on Solyzer dashboard.
About Individual Neoantigen Therapy (INT)
Individual Neoantigen Therapy (INT) is a token on the Solana blockchain. It is currently trading at $0.00000252 with a market capitalization of $2.52K. Solyzer's multi-source safety analysis rates INT as "High Risk" with a score of 0/100. Use Solyzer to perform comprehensive on-chain analysis including AI-powered safety scoring, smart money tracking, holder distribution analysis, and real-time price charts.
Is INT Safe to Buy?
Based on Solyzer's combined analysis using RugCheck.xyz on-chain data, DexScreener market metrics, INT currently has a safety score of 0/100. This indicates elevated risk. Always do your own research before investing.
How to Analyze INT
Solyzer provides professional-grade Solana token analytics. Paste the INT contract address into the analyzer to get an instant safety score, check for potential rug pull indicators, view smart money movements, and monitor real-time trading activity. Our AI engine evaluates liquidity locks, holder concentration, transaction patterns, and more to help you make informed trading decisions.